[Federal Register Volume 86, Number 140 (Monday, July 26, 2021)]
[Notices]
[Pages 40054-40055]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15801]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Center for Health Statistics (NCHS), ICD-10 Coordination 
and Maintenance (C&M) Committee Meeting

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The CDC, National Center for Health Statistics (NCHS), 
Classifications and Public Health Data Standards Staff, announces the 
following meeting of the ICD-10 Coordination and Maintenance (C&M) 
Committee meeting. This meeting is open to the public, limited only by 
audio. Online Registration is not required.

DATES: The meeting will be held on September 14, 2021, from 9:00 a.m. 
to 5:00 p.m., EDT, and September 15, 2021, from 9:00 a.m. to 5:00 p.m., 
EDT.

ADDRESSES: This is a virtual meeting. Information will be provided on 
each of our respective web pages when it becomes available. For CDC/
NCHS https://www.cdc.gov/nchs/icd/icd10cm_maintenance.htm. For CMS 
https://www.cms.gov/Medicare/Coding/ICD9ProviderDiagnosticCodes/meetings.

FOR FURTHER INFORMATION CONTACT: Traci Ramirez, Medical Systems 
Specialist, CDC, 3311 Toledo Road, Hyattsville, Maryland 20782; 
Telephone: (301) 458-4454; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The ICD-10 Coordination and Maintenance (C&M) Committee is 
a public forum for the presentation of proposed modifications to the 
International Classification of Diseases, Tenth Revision, Clinical 
Modification and ICD-10 Procedure Coding System.
    Matters To Be Considered: The tentative agenda will include 
discussions on ICD-10-CM and ICD-10-PCS topics listed below. Agenda 
items are subject to change as priorities dictate.
    Please refer to the posted agenda for updates one month prior to 
the meeting.

ICD-10-PCS Topics

1. Administration of fostamatinib(1), (2)
2. Administration of betibeglogene autotemcel (beti-cel)(1)
3. Administration of RBX2660(1)
4. Pressure-controlled Intermittent Coronary Sinus Occlusion
5. Measurement of Exhaled Nitric Oxide (FeNo)
6. Histotripsy of Liver
7. Replacement of Meniscus with Synthetic Substitute (1)
8. Section X Updates
9. Addenda and Key Updates

    (1) Applicant intends to submit a New Technology Add-on Payment 
(NTAP) application for FY 2023.
    (2) Request is for an April 1, 2022 implementation date.
    Presentations for procedure code requests are conducted by both the 
requestor and CMS during the Coordination & Maintenance Committee 
meeting. Discussion from the requestor generally focuses on the 
clinical issues for the procedure or technology, followed by the 
proposed coding options from a CMS analyst. Topics presented may also 
include requests for new procedure codes that relate to a new 
technology add-on payment (NTAP) policy request.
    CMS is continuing to modify the approach for presenting the new 
technology add-on payment (NTAP) related ICD-10-PCS procedure code 
requests that involve the administration of a therapeutic agent. 
Consistent with the requirements of section 1886(d)(5)(K)(iii) of the 
Social Security Act, applicants submitted requests to create a unique 
procedure code to describe the administration of a therapeutic agent, 
such as the option to create a new code in Section X within the ICD-10-
PCS procedure code classification. CMS will initially only display 
those meeting materials associated with the NTAP related ICD-10-PCS 
procedure code requests that involve the administration of a 
therapeutic agent on the CMS website in early August 2021 at: https://www.cms.gov/Medicare/Coding/ICD10/C-and-M-Meeting-Materials.
    The three NTAP related ICD-10-PCS procedure code requests that 
involve the administration of a therapeutic agent are:

1. Administration of fostamatinib
2. Administration of betibeglogene autotemcel (beti-cel)
3. Administration of RBX2660

    These topics will not be presented during the September 14-15, 2021 
meeting. CMS will solicit public comments regarding any clinical 
questions or coding options included for these three procedure code 
topics in advance of the meeting continuing through the end of the 
public comment period. The deadline to submit comments for topics being 
considered for April 1, 2022 implementation is October 15, 2021 and the 
deadline to submit comments for topics being considered for an October 
1, 2022 implementation is November 15, 2021. Members of the public 
should send any questions or comments to the CMS mailbox at: 
[email protected] by the designated deadline dates 
mentioned above.
    CMS intends to post a question and answer document in advance of 
the meeting to address any clinical or coding questions that members of 
the public may have submitted. Following the conclusion of the meeting, 
CMS will post an updated question and answer document to address any 
additional clinical or coding questions that members of the public may 
have submitted during the meeting that CMS was not able to address or 
that were submitted after the meeting.
    The NTAP related ICD-10-PCS procedure code requests that do not 
involve the administration of a therapeutic agent and all non-NTAP 
related procedure code requests will continue to be presented during 
the virtual meeting on September 14, 2021

[[Page 40055]]

consistent with the standard meeting process.
    CMS will make all meeting materials and related documents available 
at: https://www.cms.gov/Medicare/Coding/ICD10/C-and-M-Meeting-Materials. Any inquiries related to the procedure code topics scheduled 
for the September 14, 2021 ICD-10 Coordination and Maintenance 
Committee meeting that are under consideration for April 1, 2022 or 
October 1, 2022 implementation should be sent to the CMS mailbox at: 
[email protected].

ICD-10-CM Topics

1. Apnea of Newborn and Related Issues
2. Atrial Septal Defect
3. Craniosynostosis
4. Dementia
5. Encounter for follow-up examination after completed treatment for 
malignant neoplasm
6. Endometriosis
7. Intracranial Injury with Unknown LOC
8. Long-term (current) drug therapy
9. Primary Blast Injury
10. Problems Related to Upbringing
11. Short Stature Due to Endocrine Disorder
12. Addenda

    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-15801 Filed 7-23-21; 8:45 am]
BILLING CODE 4163-18-P